NEWS ALERT: New Drug Shows Heart Disease Reversal Promise!

By HeartHawk Latest Reply 2011-09-26 00:24:02 -0500
Started 2011-09-26 00:24:02 -0500

Dalcetrapib is a new investigational drug that raises HDL without the detrimental blood pressure raising effect that led to the failure of an earlier drug in the same class (CETP Inhibitors).

A smaller and shorter test was performed while waiting for the larger, multi-year FDA trial to conclude and that trail revealed dalcetrapib produced a clinically significance REGRESSION of arterial plaque! Read more here.

Good things are on the horizon. I can't wait!


No replies